Altacor (acquired by Esperante)
Altacor is creating a leading European specialty ophthalmology company developing and marketing a portfolio of reprofiled, low-risk and/or orphan products targeting chronic eye conditions through its own specialist sales force.
The Company’s strategy is to build its product base and commercial organisation into major countries in Europe through transactions and partnerships.
Altacor markets numerous products in the UK and Ireland (Clinitas®, Clinitas® OTC range, Clinitas® Hot Eye Compress and BioLon®) which are commercialised through its own sales and marketing organisation and network. These products are sold primarily through the healthcare system, including hospitals, GPs, pharmacies and opticians. Altacor also promote some of its products direct to patients.
The company was acquired in 2014 by Esperante – a private, Netherlands-based life science investment company – and is now headquartered in Berkshire.